July 24, 2025

Michael Platten Appointed “Ambassador” of European Research Council

Michael Platten Appointed “Ambassador” of European Research Council

The scientist from Heidelberg University is to boost trust in the funding of innovative research

Prof. Dr Michael Platten has been appointed “Ambassador for the ERC” in order to engage with the public and decision-makers about the importance of groundbreaking research and its benefit for society and industry. The neurologist is one of two scientists in Germany selected for this ambassador network by the European Research Council (ERC) and the Association of ERC Grantees (AERG). A total of 32 outstanding researchers funded with an ERC Grant have been appointed ambassadors. Michael Platten, holder of a professorship at the Medical Faculty Mannheim of Heidelberg University, works at Mannheim University Hospital and the German Cancer Research Center (DKFZ).

Porträt Michael Platten
Michael Platten | © Medizinische Fakultät Mannheim der Universität Heidelberg

In his function as ERC ambassador in Germany, Prof. Platten is mandated to contribute to communicating the value of basic research to political decision-makers, the media, and the public. This includes highlighting the contribution it makes in dealing with societal, economic, environmental and political challenges. Another key concern is to boost trust in funding for innovative research. At the same time, the scientist is a contact partner for European Research Council grantees and he is expected to inform talented researchers about the financial opportunities offered by the ERC. The office of ambassador is initially for one year and can be extended up to six times.

Michael Platten is the director of the Department of Neurology at Mannheim University Hospital and director of the Mannheim Center for Translational Neuroscience, located at the Medical Faculty Mannheim of Heidelberg University. In addition, he heads the Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology at the German Cancer Research Center. In 2024 he received an ERC Advanced Grant, which funds groundbreaking research projects. In the framework of his ERC project at the DKFZ, Prof. Platten and his team are working on developing and optimizing personalized cell-based, AI-controlled immunotherapies for malignant brain tumors.

The European Research Council is an institution established by the European Commission to finance frontier research – groundbreaking, visionary research that crosses classical borders. The Association of ERC Grantees is an international organization with a current membership of approx. 10,000 ERC grantees past and present. The ERC and AERG hope to expand the “Ambassadors for the ERC” network in the future to more European Union member states and associated countries.

Our latest News

discover more
AI solutions from the DKFZ set new standards in medical image processing

AI solutions from the DKFZ set new standards in medical image processing

Researchers at the German Cancer Research Center (DKFZ) have achieved outstanding success at this year’s world-leading forum for medical image processing and computer-assisted intervention. Two DKFZ departments competed in eight international AI competitions – and won seven of them. The successes cover key areas of oncology – from early detection and diagnosis to therapy support […]

Role of intestinal bacteria in the development of colorectal cancer: Emmy Noether grant for DKFZ researcher Jens Puschhof

Role of intestinal bacteria in the development of colorectal cancer: Emmy Noether grant for DKFZ researcher Jens Puschhof

The German Research Foundation (DFG) is funding a new Emmy Noether project led by Jens Puschhof from the German Cancer Research Center (DKFZ). With this project, the junior researcher aims to decipher the role of certain intestinal bacteria in the earliest stages of colorectal cancer development and investigate how this process can be halted. The […]

How immune cells become accomplices of tumors – Langener Wissenschaftspreis awarded to DKFZ researcher Daniel Kirschenbaum

How immune cells become accomplices of tumors – Langener Wissenschaftspreis awarded to DKFZ researcher Daniel Kirschenbaum

Daniel Kirschenbaum has developed an experimental method for investigating immune responses in living organisms with high temporal resolution. The technique enabled him and his colleagues to reconstruct the temporal sequence of the immune response in malignant brain tumors for the first time. This opens up new perspectives for the development of targeted and temporally precise […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp